David Hovland
About David Hovland
David Hovland is the Chief Regulatory Officer with over 20 years of R&D experience in the pharmaceutical industry, contributing to the development and registration of various pharmaceutical products.
David Hovland - Chief Regulatory Officer
David Hovland currently holds the position of Chief Regulatory Officer. With over 20 years of experience in research and development within the pharmaceutical industry, David has a robust background in navigating the complexities of drug development and regulatory requirements. His extensive expertise is crucial in guiding organizations through the regulatory landscapes to successfully bring pharmaceutical products to market.
David Hovland's Experience in Pharmaceutical R&D
David Hovland has over two decades of experience in research and development in the pharmaceutical sector. Throughout his career, he has contributed significantly to the global development and registration of both small and large molecule pharmaceutical products. His contributions span the entire drug development lifecycle, from early research to final regulatory approvals.
David Hovland's Previous Roles at Urovant Sciences and Allergan
Before his current role, David Hovland served as Senior Vice President of Global Regulatory Affairs and Quality at Urovant Sciences. He also held leadership roles at Allergan within their Global Regulatory Affairs organization, where he was the Therapeutic Area Head for Neurology, Urology, and Dermatology. These positions involved leading regulatory strategies and ensuring compliance with global regulatory standards.
David Hovland's Tenure at Amgen
David Hovland has also been a part of Amgen's Global Regulatory Affairs and Safety organization. His work at Amgen involved ensuring the safety and regulatory compliance of the company's pharmaceutical products. This role further solidified his reputation as a regulatory affairs expert in the pharmaceutical industry.
David Hovland's Educational Background
David Hovland holds a Ph.D. in Environmental Health Sciences from the School of Public Health at the University of California, Los Angeles. Additionally, he earned a B.S. in Bioresource Sciences from the College of Natural Resources at the University of California, Berkeley. His academic background in environmental and bioresource sciences provides a strong foundation for his work in pharmaceutical research and regulatory affairs.